James Peyer, Founder and CEO, Cambrian BioPharma
James Peyer is the Founder and CEO of Cambrian BioPharma, a diversified pharmaceutical R&D company creating breakthrough therapeutics that target fundamental mechanisms of our natural degeneration we call aging. Cambrian founds, invests in, and builds biotech companies. He created Cambrian to explore the potential of our newfound knowledge of what makes us age, believing that medicines derived from this knowledge will enable the greatest medical breakthroughs of the 21st century. Before Cambrian, James founded and built Apollo Ventures, a life science investment arm of a group of impact-minded family offices in Europe. He built Apollo from its founding to being one of the world’s leading investors in longevity biotech, deploying $20M and raising over $50M in the first three years of operations. He led investments in Cleara Biotech, Aeovian Pharmaceuticals, and Samsara Therapeutics, and served on the Board and/or in executive roles for all three companies. Before Apollo, James worked as a McKinsey consultant, earned his PhD at UTSW studying stem cell biology as a National Science Foundation fellow, and got his undergraduate with special honors from the University of Chicago.